Unknown NA INTERVENTIONAL 1-arm NCT04921605

Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation

A Clinical Study of Management of Severe Tricuspid Regurgitation With Transcatheter Mitral Valve Clamping System

Sponsor: Hangzhou Valgen Medtech Co., Ltd

Interventions DragonFly transcatheter mitral valve clamping system

Updated 5 times since 2021 Last updated: Mar 26, 2022 Started: Dec 15, 2020 Primary completion: Sep 15, 2022 Completion: Jun 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Tricuspid Regurgitation and is currently ongoing. Hangzhou Valgen Medtech Co., Ltd leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Apr 2022 — Jul 2023 [monthly]

Enrolling By Invitation NA
Sep 2021 — Apr 2022 [monthly]

Enrolling By Invitation NA

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hangzhou Valgen Medtech Co., Ltd

Data source: Hangzhou Valgen Medtech Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China